Cladribine effects on emotional awareness and reasoning: The CLEAR study
These results provide the first evidence that RRMS patients receiving cladribine (Cladribine) exhibit stasis in an important area of neurocognitive function relative to healthy controls.
Authors
- Sarah P. Coundouris (ORCID: https://orcid.org/0000-0003-2084-2929)
- Julie D. Henry (ORCID: https://orcid.org/0000-0002-2081-3717)
- Stefan Blum (ORCID: https://orcid.org/0000-0002-2702-3742)
- Nithin Manchery (ORCID: https://orcid.org/0000-0002-4319-6125)
- Alexandra G. Adams (ORCID: https://orcid.org/0000-0001-6062-8885)
- Lauren Gomes
Institutions
- The University of Queensland (AU)
- Princess Alexandra Hospital (AU)
- University of Newcastle Australia (AU)
Publication Details
- Journal
- Multiple Sclerosis and Related Disorders
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1016/j.msard.2025.106566
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Merck